Mark Perrin
2016
In 2016, Mark Perrin earned a total compensation of $741.9K as Chief Executive Officer and Chairman of the Board at InVivo Therapeutics Holdings, a 61% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $111,263 |
|---|---|
| Salary | $445,050 |
| Other | $185,623 |
| Total | $741,936 |
Perrin received $445.1K in salary, accounting for 60% of the total pay in 2016.
Perrin also received $111.3K in non-equity incentive plan and $185.6K in other compensation.
Rankings
In 2016, Mark Perrin's compensation ranked 9,629th out of 14,075 executives tracked by ExecPay. In other words, Perrin earned more than 31.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,629 out of 14,075 | 32nd |
Division Manufacturing | 3,729 out of 5,486 | 32nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 489 out of 819 | 40th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 282 out of 502 | 44th |
Industry Surgical and Medical Instruments and Apparatus | 167 out of 305 | 45th |
Source: SEC filing on April 25, 2017.
Perrin's colleagues
We found six more compensation records of executives who worked with Mark Perrin at InVivo Therapeutics Holdings in 2016.
2016
Pamela Stahl
InVivo Therapeutics Holdings
Chief Commercial Officer
2016
Christopher McNulty
InVivo Therapeutics Holdings
Chief Financial Officer
2016
Thomas Ulich
InVivo Therapeutics Holdings
Chief Scientific Officer
2016
Lorianne Masuoka
InVivo Therapeutics Holdings
Chief Medical Officer
2016
Steven McAllister
InVivo Therapeutics Holdings
Chief Financial Officer
2016
Tamara Joseph
InVivo Therapeutics Holdings